Fingerprint
Dive into the research topics of 'ABCL-023 frontMIND: A Phase III, Randomized, Double-Blind Study of Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP Alone for Newly Diagnosed High-Intermediate and High-Risk Diffuse Large B-Cell Lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically